NSG BioLabs fuels biotech innovation in Singapore and Southeast Asia

NSG BioLabs, Singapore's largest provider of biotech co-working laboratory and office space, has announced partnerships with Enterprise Singapore (EnterpriseSG), the Singapore government agency championing enterprise development, and Merck, a leading science and technology company, to bolster the biotech landscape by providing needed resources such as funding, expertise and networks to advance startup research and development (R&D).

The company has also successfully concluded a $14.5 million financing round led by Celadon Partners, an Asian private equity firm, and ClavystBio, a life science investor and venture builder set up by Temasek to accelerate the commercialisation of breakthrough ideas to health impact.

These achievements reaffirm NSG BioLabs' strength and expertise in providing high-quality, well-managed, and turnkey Biosafety Level 2 (BSL-2) certified laboratory and office spaces.